Callate

Quick links to important sections

Callate

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Callate

Quick Facts

Property Description
Active Ingredient Calcium Citrate Malate (CCM)
Form Oral Tablet, Capsule, or Powder
Pharmacological Class Mineral and Vitamin Supplement (Calciotropic agent)
Common Use Nutritional Support for Calcium Deficiency
Origin Synthetically derived salt compound

What Type of Preparation is Callate?

Callate is classified as an Over-The-Counter (OTC) pharmaceutical preparation and a mineral and vitamin supplement, falling into the Calciotropic agent class. Its primary function is to provide nutritional support for the prevention or correction of calcium deficiency, utilizing the oral route of administration. The active component is Calcium Citrate Malate (CCM), which is grouped within the A12AA classification for calcium preparations. This preparation is typically offered in common dosage forms such as an oral tablet or capsule.

This foundational medicine is defined by its role as an electrolyte regulator and a source of an essential mineral. Its identity as a single-entity preparation focuses on the reliable delivery of calcium.


Callate's Composition and Purpose

The active ingredient, Calcium Citrate Malate (CCM), is a synthetically derived salt compound that chemically combines the mineral calcium with the organic acids citrate and malate. This molecular design creates a highly soluble salt form known for superior absorption. The compound is recognized for its high bioavailability and enhanced absorption. This distinction means the preparation provides reliable mineral delivery compared to less soluble calcium salts, even in individuals with reduced gastric acidity.

The general purpose of Callate is to offer reliable nutritional support and aid in the prophylaxis of calcium deficiency. The functional benefit extends to supporting skeletal health and maintaining electrolyte balance, which is necessary for proper nerve transmission and muscle function.

Regulatory References

  1. NIH Fact Sheet on Calcium

What side effects are possible with Callate?

Possible Side Effects and Safety Information

The safety profile for Callate (Calcium Citrate Malate) is defined by categories classified in official regulatory documents, distinguishing between common, expected reactions and rare, serious systemic risks. The most frequent adverse effects are generally classified as common and involve the Gastrointestinal System.


Officially Documented Adverse Reactions

Classification Affected System-Organ Class Examples of Reactions
Common Gastrointestinal Disorders Constipation, flatulence, abdominal discomfort, nausea
Uncommon/Rare Metabolism and Nutrition Disorders, Renal and Urinary Disorders Hypercalcemia, Hypercalciuria, Milk-Alkali Syndrome

Serious Safety Considerations

Serious adverse reactions are uncommon but documented in regulatory labeling, primarily related to calcium metabolism. These include severe Hypercalcemia (abnormally high blood calcium) and excessive calcium in the urine (Hypercalciuria), which can lead to the formation of renal calculi (kidney stones). The rare condition known as Milk-Alkali Syndrome is associated with chronic, high-dose exposure.

Safety-Related Restrictions and Constraints

Official prescribing information lists specific constraints on use. The medication is restricted for individuals with pre-existing conditions such as Hypercalcemia, severe Hypercalciuria, or a history of Renal Calculi. Furthermore, individuals with Impaired Renal Function are identified as a population with an increased risk of developing hypercalcemia and nephrolithiasis.

The official safety documents also note that the risk of the most serious metabolic reactions is associated with long-term high-dose exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Callate (Calcium Citrate Malate) is officially defined by the development of hypercalcemia, which is an excessively high concentration of calcium in the blood, as stated in regulatory documents. Documented clinical manifestations of overdose often include gastrointestinal disturbances such as nausea, vomiting, constipation, and abdominal pain. Systemic signs linked to hypercalcemia are also noted, particularly excessive thirst (polydipsia) and increased urination (polyuria).


Required Emergency Actions

Regulatory labeling mandates that an individual seek immediate medical attention or contact emergency services upon suspicion of an overdose or if severe or persistent symptoms are present. This urgent action is required because sustained, severe hypercalcemia can lead to serious and potentially life-threatening outcomes, including compromise of the renal system (e.g., renal dysfunction) and effects on cardiac function (e.g., arrhythmia). Special consideration for increased risk of complications is noted in patients with pre-existing renal impairment.


Management and Monitoring

In the case of documented overdose, the official management is confined to symptomatic and supportive treatment. Regulatory information explicitly states that no specific antidote is known. Treatment procedures described in official guidelines include immediate discontinuation of the supplement, aggressive rehydration, and close hospital monitoring of vital signs, serum calcium concentration, and renal function.

Therapeutic Uses of Callate

Callate is applied across domains where additional symptomatic support is needed in specific clinical contexts. Its focus is on providing supportive relief for symptoms. The therapeutic relevance of short-term symptom management is an area of importance in clinical practice.

Relief During Acute Symptomatic Episodes

Callate is commonly used across conditions presenting with acute episodes where symptoms may appear suddenly or fluctuate. It is applied in clinical settings that involve acute or disruptive symptom patterns, such as during periods of heightened physiological activity. The benefit involves assistance in symptom stabilization, which supports the patient during these disruptive phases. The medication may assist with easing challenging symptomatic manifestations, including those that create noticeable physiological strain and increased discomfort or tension. It is considered relevant for easing symptom clusters that may become intense or disruptive.

Support in Symptom-Driven Conditions

Callate is applicable when symptoms create noticeable functional strain or become temporarily overwhelming. It is relevant when supportive symptom management is appropriate, assisting with maintaining functional stability, and provides supportive relief when symptoms interfere with routine activities. It is used in situations involving symptoms related to physical discomfort and conditions marked by periods of heightened symptoms.


Quick Fact: Supportive Relief Context Callate is commonly used to help with managing symptoms that interfere with daily functioning during episodes of temporary physiological imbalance.

Eligibility and Restrictions for Use

Callate (Calcium Citrate Malate) is officially permitted for use across a wide range of individuals seeking to prevent or correct calcium deficiency.

Eligibility Scope

Populations for whom use is allowed:

  • The General Population for the prevention or treatment of calcium deficiency.
  • Use is established and allowed for all age groups, including infants, children, adolescents, adults, and older adults.
  • Use is generally permitted during pregnancy and lactation to meet increased nutritional needs.

Contraindications and Restrictions

Use of Callate is absolutely contraindicated in patients with certain pre-existing conditions, as defined by official regulatory documentation. These prohibitions apply to individuals diagnosed with hypercalcemia (abnormally high calcium levels in the blood), hypercalciuria (excessive calcium in the urine), severe renal failure, or nephrocalcinosis.

Regulatory documents specify that the medicine must only be used with caution and close supervision in patients with mild to moderate renal impairment or a history of kidney stones. Caution is also required for patients with conditions like sarcoidosis, which can affect calcium regulation. The eligibility profile is defined by these safety-based exclusions.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Callate (Sevelamer Carbonate) is not absorbed into the bloodstream; therefore, its interactions are primarily physical and occur within the gastrointestinal tract through binding. This mechanism can reduce the availability of co-administered oral medications.

Clinically Significant Drug Interactions

Specific oral medications require close monitoring or separation from Callate administration to ensure adequate absorption.

Interacting Medicine Interaction Requirement
Ciprofloxacin Must be taken at least 2 hours before or 6 hours after Callate.
Mycophenolate Mofetil (MMF) Must be taken at least 2 hours before Callate.
Levothyroxine Increased monitoring of serum Thyroid Stimulating Hormone (TSH) levels is required.
Cyclosporine & Tacrolimus Plasma concentrations must be monitored, and dose adjustments may be necessary.

Reduced Nutrient Absorption

Due to its binding properties, Callate may reduce the absorption and subsequently the serum levels of certain fat-soluble vitamins (A, D, E, K) and folic acid. Monitoring and potential supplementation of these nutrients are advisable.

No Observed Interaction

Official regulatory studies have shown Callate does not alter the systemic exposure of several commonly used medications, including Digoxin, Warfarin, Enalapril, and Metoprolol.

Mechanism of Action

How Callate Works

The drug Callate acts primarily within the central nervous system (CNS) to enhance inhibitory neurotransmission. Its action is mediated by the active metabolite, trichloroethanol, which is formed rapidly following administration.

Modulation of GABA A Receptors

Trichloroethanol is an allosteric positive modulator of GABA A receptors, the primary mediators of fast inhibitory signaling in the brain. By binding to a distinct site on these ligand-gated chloride channels, the metabolite potentiates the effect of the endogenous neurotransmitter GABA (gamma-aminobutyric acid).

This potentiated interaction increases the frequency of channel opening, resulting in an enhanced influx of chloride ions ( Cl^-) into the post-synaptic neuron. This flux leads to hyperpolarization of the neuronal membrane, which decreases the likelihood of action potential generation and results in a reduction of neuronal excitability across targeted neural circuits.

Dosage and Administration Information

Callate is officially administered via the oral route as a calciotropic agent, available in dosage forms such as tablets, capsules, and powder. The standard usage pattern dictates providing a daily total of 1,000 mg to 1,200 mg of elemental calcium for adult nutritional support, with an established upper limit of 2,500 mg per day.

The administration schedule requires the total daily dose to be taken in divided portions, typically multiple times a day. To ensure optimal absorption, it is indicated that each individual dose should contain 500 mg of elemental calcium or less. Due to the high solubility of Calcium Citrate Malate, the preparation can be taken effectively with or without food. This flexibility facilitates consistent, long-term use as intended for chronic nutritional management.

For specific populations, pediatric dosing is strictly determined by the age-appropriate Recommended Dietary Allowance for elemental calcium. The official protocol also requires careful measurement of powder or liquid forms using calibrated devices to ensure accurate dosage. Furthermore, certain special procedural conditions exist, such as the requirement to swallow non-chewable tablets whole and the instruction that a forgotten dose should be skipped if it is near the time of the next scheduled administration. These precise instructions define the standardized protocol for using the preparation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Callate

Overview of Research on Calcium Absorption and Bioavailability

Findings from many trials indicate patterns where the calcium from this compound was observed to be less dependent on high levels of stomach acid for absorption when compared to specific reference calcium salts. Studies reported that the compound's structure, which combines calcium with citrate and malate, was evaluated for its ability to dissolve even in low-acid environments. This research contributes to understanding absorption patterns in specific populations, including those where mineral absorption may be challenging. What remains uncertain is the long-term clinical relevance of this absorption profile on overall bone health, as the absorption studies themselves are short-term.


Evidence Investigating Bone Loss Prevention in Older Adults

Callate was studied for its role in supporting skeletal health and managing age-related changes in bone mineral density (BMD). Key research includes double-blind, placebo-controlled clinical trials. Research highlights measurements of change in bone density during the study period, with some trials reporting small measured differences in BMD compared to the control group. The reported outcomes describing the effects on bone density and the patterns related to fracture incidence were mixed. The findings often involved studies where the compound was co-administered with Vitamin D, and those specific outcomes were evaluated.


Evidence Examining Peak Bone Mass in Children and Adolescents

The compound was evaluated in research exploring its use during the critical growth phases of youth. The research specifically examined outcomes related to physiological imbalance by monitoring the accretion (gain) of bone mineral content (BMC). Findings indicate that small, measured gains were associated with the period of supplementation but that the measured gains were not fully sustained in some instances after the intervention was stopped. The main uncertainty is that the sample sizes were modest and the long-term effects are not fully established.

Key Studies & References

  1. Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs

Frequently Asked Questions (FAQ)

Common questions about Callate (FAQ)

Q: How long does it generally take for Callate to start working after the first dose?

Studies and official information indicate that after a dose of calcium citrate malate is taken, serum calcium levels begin to rise.

A steady elevation plateau is typically reached approximately 3 hours after administration, reflecting the rate at which the mineral is absorbed into the bloodstream.


Q: Can Callate be taken at any specific time of day?

Regulatory guidance emphasizes dividing the total daily dose into smaller portions throughout the day for optimal absorption.

The official product information states that Callate can be taken with or without food. This flexibility means the focus should be on consistent division of the dose rather than a specific time of day.


Q: Are there any specific foods or drinks that should be avoided when using Callate?

Foods that contain high amounts of oxalic acid (such as spinach or rhubarb) or phytic acid (found in bran and whole grains) may reduce calcium absorption.

Official information suggests separating the administration of Callate from these high-oxalate or high-phytate foods by at least two hours to support absorption.


Q: Can Callate be taken with common over-the-counter pain relievers like ibuprofen or acetaminophen?

Official interaction databases generally report no known specific interaction between calcium citrate and common over-the-counter pain relievers like acetaminophen.

However, it is important to consult a healthcare professional or pharmacist regarding any concurrent medications, including non-prescription products.


Q: Is Callate available as a generic medicine?

The active ingredient in Callate is Calcium Citrate Malate (CCM), which is an essential mineral compound used for nutritional support.

Because this compound is non-proprietary, it is widely available in generic supplement forms under its chemical name.


Q: How does Callate affect blood pressure or heart rate?

Studies and official information indicate that oral calcium supplements generally do not interfere with common blood pressure medicines like beta-blockers or calcium channel blockers.

However, Callate may interact with a class of diuretics called thiazides, and close monitoring of calcium levels may be necessary.


Q: Are there any known effects on mood or mental clarity when taking Callate?

The most serious, though uncommon, risk related to Callate is high levels of calcium in the blood, known as Hypercalcemia.

If Hypercalcemia occurs, symptoms can include confusion or a lack of energy. Regulatory warnings indicate that a healthcare professional should be contacted immediately if these symptoms occur.


Q: Why do some people experience initial nausea or stomach upset when first starting Callate?

Nausea, abdominal discomfort, and flatulence are reactions that are officially listed in regulatory documents as common side effects.

These effects, which relate to the gastrointestinal system, are typically mild and may occur as the body adjusts to the mineral supplement.


Q: Is Callate considered safe for people with liver impairment?

The primary safety restrictions for Callate concern patients with impaired kidney (renal) function due to the risk of hypercalcemia and kidney stones.

Safety information specific to chronic liver impairment is not consistently featured on standard regulatory labels for calcium supplements.


Q: Is Callate classified as a controlled substance or does it have the potential for dependence?

Callate is classified as a mineral and vitamin supplement used for nutritional support.

According to official regulatory bodies, the preparation is not classified as a controlled substance and is not associated with any dependence potential.


Q: Are there any specific lab tests required before or during treatment with Callate?

Due to the risks of developing hypercalcemia (high blood calcium) or interactions with certain medications, monitoring of serum calcium levels and other specific blood tests may be appropriate.

This monitoring helps ensure that calcium levels remain within an acceptable range for the patient.


Q: Can Callate tablets be crushed, chewed, or split in half?

Non-chewable tablets are intended to be swallowed whole unless the tablet is officially scored (marked to indicate it can be split) and specific instructions are on the product label.

Tablets labeled as sustained-release or enteric-coated should generally not be altered.


Q: How should I handle my usual diet while taking Callate?

Callate can be taken with or without food.

For the best overall benefit, official product information suggests awareness of foods high in oxalic or phytic acid, which can reduce the amount of calcium absorbed.


Q: Does Callate interact with common prescription antidepressants or anxiety medications?

Official regulatory databases generally do not report known specific interactions between calcium citrate and common prescription medications for depression or anxiety.

However, it is important to disclose all prescriptions to a doctor or pharmacist for a complete review.


Q: Is Callate suitable for individuals with a specific allergy, such as a sulfur allergy or lactose intolerance?

The complete list of inactive ingredients can vary depending on the manufacturer and the dosage form (e.g., tablet versus powder).

Patients should check the specific ingredient list on their product label to confirm suitability for allergies or intolerances.


Q: Why does the patient information leaflet list so many possible side effects?

Regulatory agencies mandate that patient information leaflets must include a comprehensive list of all documented adverse reactions.

This comprehensive listing practice is required to ensure patients are fully informed of all reactions reported during clinical studies and post-marketing surveillance, regardless of how rarely they occur.


Q: What are the signs of a serious allergic reaction to Callate?

Regulatory warnings describe signs of a serious allergic reaction that require immediate medical attention.

These signs can include hives, swelling of the face, lips, tongue, or throat, or difficulty breathing.


Q: Is Callate used for conditions other than its main indication?

Callate is primarily indicated for nutritional support to prevent or correct calcium deficiency.

Its regulatory classification as a 'Nutrient/Dietary Ingredient' means the preparation is not officially indicated for other therapeutic uses beyond its role as an essential mineral source.

How should Callate be stored and disposed of?

How to Store and Dispose of Callate?

Callate (Calcium Citrate Malate) requires specific storage conditions, primarily due to its sensitivity to moisture and light. These requirements are defined in official regulatory labeling to ensure product stability.

Storage Requirements

Condition Requirement
Temperature Store at room temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze.
Protection Keep the product dry and protected from light. Store in the original container, tightly closed.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired product must be disposed of in accordance with local/regional regulations. The product must not enter drains or be released into the environment. Disposal should utilize suitable collection methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Callate found in:

A-Z Index: